Attorneys for a cannabis company and advocacy group that are set to testify in the Drug Enforcement Administration’s (DEA) marijuana rescheduling hearing process beginning this month say new evidence ...

DEA judge orders agency to respond to allegations of opposing marijuana rescheduling and improper communication with opponents. Cannabis stocks declined in 2024 due to concerns about DEA review.

Welcome back to The Week in Weed, your Friday look at what’s happening in the world of legalized marijuana. New York released updated ...

Advocates accuse Drug Enforcement Administration of blocking the reclassification of cannabis as a Schedule III drug under ...

The latest announcement is out from Village Farms International ( (VFF) ).

Shares of cannabis stocks slumped after a company set to testify in the Drug Enforcement Administration's rescheduling hearings accused the agency of obstructing the rulemaking process.

Boise expressed frustration over the blockade, noting, "MMJ has not been able to grow the specific marijuana plant cultivars needed for our API development due to significant delays in our DEA ...

Allegations of widespread DEA wrongdoing and bias ... aims to ensure a fair examination of the proposal to reschedule marijuana from Schedule I to Schedule III. The evidence includes claims ...

Alexander Malyshev and Sarah Ganley of Carter Ledyard & Milburn LLP discuss what the cannabis sector can expect as 2025 ...

Recreational cannabis is now legal in 24 states and three more could legalize some form of marijuana sales this year. But ...

The agency is accused of improperly opposing the rescheduling proposal, conspiring with prohibitionist groups and stacking ...